Cargando…

Asymptomatic cryptococcal antigenemia in HIV-infected patients: a review of recent studies

The prevalence of asymptomatic cryptococcal antigenemia (ACA) in human immunodeficiency virus (HIV) infected individuals has been observed to be elevated. The prevalence of ACA ranges from 1.3% to 13%, with different rates of prevalence in various regions of the world. We reviewed studies conducted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xiao-Lei, Zhao, Ting, Harypursat, Vijay, Lu, Yan-Qiu, Li, Yan, Chen, Yao-Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631590/ https://www.ncbi.nlm.nih.gov/pubmed/33273336 http://dx.doi.org/10.1097/CM9.0000000000001134

Ejemplares similares

Antibody Responses in HIV-Infected Patients With Advanced Immunosuppression and Asymptomatic Cryptococcal Antigenemia
por: Hlupeni, Admire, et al.
Publicado: (2018)

375. Cryptococcal Antigenemia in Advanced HIV Infection
por: Ahuja, Jatin, et al.
Publicado: (2019)

Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal Antigenemia
por: Lehman, Alice, et al.
Publicado: (2023)

Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia
por: Ganiem, Ahmad Rizal, et al.
Publicado: (2014)

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts
por: Montgomery, Martha P., et al.
Publicado: (2017)

A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria
por: Oladele, Rita O., et al.
Publicado: (2023)

Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia
por: Xu, Miaomiao, et al.
Publicado: (2020)

A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections: Study protocol for the optimal early intervention for cryptococcal antigenemia in HIV-infected patients
por: Sun, Feng, et al.
Publicado: (2020)

Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis
por: Zhao, Ting, et al.
Publicado: (2021)

Increased mortality among HIV infected patients with cryptococcal antigenemia in Guinea-Bissau
por: Thomsen, Ditte, et al.
Publicado: (2018)

Long Term 5-Year Survival of Persons with Cryptococcal Meningitis or Asymptomatic Subclinical Antigenemia in Uganda
por: Butler, Elissa K., et al.
Publicado: (2012)

Opportunistic Cryptococcal Antigenemia in the HAART Era at HIV Epidemic Settings of Northwest Ethiopia
por: Negash, Markos, et al.
Publicado: (2020)

High Prevalence of Cryptococcal Antigenemia among HIV-infected Patients Receiving Antiretroviral Therapy in Ethiopia
por: Alemu, Abere Shiferaw, et al.
Publicado: (2013)

Magnitude of Cryptococcal Antigenemia among HIV Infected Patients at a Referral Hospital, Northwest Ethiopia
por: Derbie, Awoke, et al.
Publicado: (2018)

Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study
por: Huang, Sung-Hsi, et al.
Publicado: (2021)

Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program – Vietnam
por: Smith, Rachel M., et al.
Publicado: (2013)

The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a Southwest London cohort()
por: Patel, Sheel, et al.
Publicado: (2013)

Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review
por: Derbie, Awoke, et al.
Publicado: (2020)

Comment on “Cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)”
por: Joob, Beuy, et al.
Publicado: (2012)

The Effect of Early vs. Deferred Antiretroviral Therapy Initiation in HIV-Infected Patients With Cryptococcal Meningitis: A Multicenter Prospective Randomized Controlled Analysis in China
por: Zhao, Ting, et al.
Publicado: (2021)

No Association of Cryptococcal Antigenemia with Poor Outcomes among Antiretroviral Therapy-Experienced HIV-Infected Patients in Addis Ababa, Ethiopia
por: Smitson, Christopher C., et al.
Publicado: (2014)

Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm(3)
por: Wykowski, James, et al.
Publicado: (2020)

Prior Pulmonary Tuberculosis Is a Risk Factor for Asymptomatic Cryptococcal Antigenemia in a Cohort of Adults With Advanced Human Immunodeficiency Virus Disease
por: Wake, Rachel M, et al.
Publicado: (2022)

Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study
por: Oyella, Jacinta, et al.
Publicado: (2012)

Comparison of Cryptococcal Antigenemia between Antiretroviral Naïve and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia
por: Beyene, Tafese, et al.
Publicado: (2013)

Prevalence of Advanced HIV Disease, Cryptococcal Antigenemia, and Suboptimal Clinical Outcomes Among Those Enrolled in Care in Vietnam
por: Dat, Vu Quoc, et al.
Publicado: (2021)

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications
por: Wake, Rachel M, et al.
Publicado: (2022)

Response to comment on “Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)”
por: Oyella, Jacinta, et al.
Publicado: (2012)

Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence
por: Oladele, Rita O., et al.
Publicado: (2016)

High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique
por: Deiss, Robert, et al.
Publicado: (2021)

Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic
por: Reepalu, Anton, et al.
Publicado: (2015)

Cryptococcal antigenemia and associated risk factors among ART‐naïve and ART‐experienced HIV‐infected peoples at selected health institutions of Mekelle, Northern Ethiopia
por: Hailu, Kibra, et al.
Publicado: (2018)

Six months survival and risk factors for attrition for patients detected with cryptococcal antigenemia through screening in Malawi
por: Chisale, Master R. O., et al.
Publicado: (2023)

Prevalence of Cryptococcal Antigenemia and Associated Factors among HIV/AIDS Patients at Felege-Hiwot Referral Hospital, Bahir Dar, Northwest Ethiopia
por: Jemal, Mohabaw, et al.
Publicado: (2021)

Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial
por: Meya, David B., et al.
Publicado: (2019)

Prevalence and Associated Factors of Cryptococcal Antigenemia in HIV-Infected Patients with CD4 < 200 Cells/µL in São Paulo, Brazil: A Bayesian Analysis
por: Mimicos, Evanthia Vetos, et al.
Publicado: (2022)

Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality
por: Letang, Emilio, et al.
Publicado: (2015)

Prevalence of Cryptococcal Antigenemia and associated factors among HIV/AIDS patients on second-line antiretroviral therapy at two hospitals in Western Oromia, Ethiopia
por: Geda, Nuguse, et al.
Publicado: (2019)

Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa
por: Larson, Bruce A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qcvjfg3q7nuirsldhmdbpv4l6o